Zurcher Kantonalbank Zurich Cantonalbank Sells 78,994 Shares of Xylem Inc. (NYSE:XYL)

Zurcher Kantonalbank Zurich Cantonalbank trimmed its position in Xylem Inc. (NYSE:XYL) by 22.8% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 267,685 shares of the industrial products company’s stock after selling 78,994 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in Xylem were worth $30,612,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in XYL. Bruce G. Allen Investments LLC bought a new stake in Xylem during the 4th quarter worth approximately $27,000. NBC Securities Inc. bought a new stake in Xylem during the 3rd quarter worth approximately $38,000. KB Financial Partners LLC bought a new stake in Xylem during the 1st quarter worth approximately $42,000. Coppell Advisory Solutions LLC bought a new stake in Xylem during the 2nd quarter worth approximately $45,000. Finally, Orion Capital Management LLC bought a new stake in Xylem during the 3rd quarter worth approximately $48,000. 87.96% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently weighed in on XYL shares. Citigroup boosted their target price on Xylem from $126.00 to $139.00 and gave the stock a “neutral” rating in a research note on Monday, April 8th. Robert W. Baird boosted their target price on Xylem from $141.00 to $148.00 and gave the stock an “outperform” rating in a research note on Thursday, March 21st. Raymond James upgraded Xylem from an “underperform” rating to a “market perform” rating in a research note on Thursday, January 4th. Royal Bank of Canada boosted their target price on Xylem from $140.00 to $145.00 and gave the stock an “outperform” rating in a research note on Wednesday, February 7th. Finally, BNP Paribas started coverage on Xylem in a research note on Tuesday, March 12th. They issued an “outperform” rating and a $150.00 price objective on the stock. Four equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. Based on data from MarketBeat.com, Xylem has a consensus rating of “Moderate Buy” and a consensus target price of $135.44.

Insiders Place Their Bets

In other Xylem news, CAO Geri-Michelle Mcshane sold 1,000 shares of the stock in a transaction on Tuesday, February 20th. The stock was sold at an average price of $122.89, for a total transaction of $122,890.00. Following the sale, the chief accounting officer now owns 2,935 shares in the company, valued at $360,682.15. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. In other news, SVP Franz Cerwinka sold 2,408 shares of the company’s stock in a transaction on Thursday, February 8th. The shares were sold at an average price of $121.79, for a total value of $293,270.32. Following the transaction, the senior vice president now owns 11,750 shares of the company’s stock, valued at $1,431,032.50. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, CAO Geri-Michelle Mcshane sold 1,000 shares of the company’s stock in a transaction on Tuesday, February 20th. The stock was sold at an average price of $122.89, for a total transaction of $122,890.00. Following the completion of the transaction, the chief accounting officer now directly owns 2,935 shares in the company, valued at approximately $360,682.15. The disclosure for this sale can be found here. Company insiders own 0.27% of the company’s stock.

Xylem Trading Up 0.6 %

NYSE:XYL opened at $128.02 on Wednesday. The company has a market cap of $31.03 billion, a P/E ratio of 47.07, a P/E/G ratio of 2.54 and a beta of 1.10. The stock’s fifty day moving average price is $126.79 and its two-hundred day moving average price is $111.91. Xylem Inc. has a 1 year low of $87.59 and a 1 year high of $130.86. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.76 and a quick ratio of 1.30.

Xylem (NYSE:XYL) last posted its earnings results on Tuesday, February 6th. The industrial products company reported $0.99 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.96 by $0.03. The firm had revenue of $2.12 billion for the quarter, compared to the consensus estimate of $2.05 billion. Xylem had a return on equity of 9.65% and a net margin of 8.27%. The business’s quarterly revenue was up 40.6% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.92 earnings per share. As a group, analysts expect that Xylem Inc. will post 4.13 EPS for the current year.

Xylem Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, March 20th. Shareholders of record on Wednesday, February 21st were given a dividend of $0.36 per share. The ex-dividend date of this dividend was Tuesday, February 20th. This represents a $1.44 annualized dividend and a dividend yield of 1.12%. This is an increase from Xylem’s previous quarterly dividend of $0.33. Xylem’s dividend payout ratio is currently 52.94%.

About Xylem

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.